MEDICURE INC. Files August 2024 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Aug 14, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Aug 14, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, routine-report
Related Tickers: MCUR
TL;DR
MEDICURE INC. (MCUR) filed its August 6-K, confirming foreign private issuer status.
AI Summary
On August 14, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private issuer filing under the 1934 Act. MEDICURE INC. is based in Winnipeg, Canada, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides routine updates for investors and the market regarding MEDICURE INC.'s status as a foreign private issuer. It confirms their ongoing reporting obligations with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would typically increase risk.
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- 20240814 (date) — Filing Date
- Winnipeg, MB Canada (location) — Company Headquarters
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of the issuer's home country, or which it furnishes or makes public to its security holders.
What is MEDICURE INC.'s SIC code?
MEDICURE INC.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Does MEDICURE INC. file annual reports on Form 20-F or 40-F?
MEDICURE INC. indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for MEDICURE INC.?
The principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
Is MEDICURE INC. submitting this Form 6-K in paper format?
The filing indicates that MEDICURE INC. is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-08-14 17:01:38
Filing Documents
- med_6k.htm (6-K) — 10KB
- med_ex991.htm (EX-99.1) — 490KB
- med_ex992.htm (EX-99.2) — 437KB
- med_ex993.htm (EX-99.3) — 9KB
- med_ex994.htm (EX-99.4) — 9KB
- med_ex991img6.jpg (GRAPHIC) — 3KB
- med_ex991img4.jpg (GRAPHIC) — 5KB
- med_ex992img5.jpg (GRAPHIC) — 3KB
- med_ex992img4.jpg (GRAPHIC) — 2KB
- med_ex992img3.jpg (GRAPHIC) — 5KB
- 0001654954-24-010668.txt ( ) — 984KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: August 14, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3